Abstract: The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-?B for the treatment or prevention of muscular wasting disease, including muscular dystrophy.
Type:
Application
Filed:
April 5, 2011
Publication date:
August 1, 2013
Applicant:
VALIDUS BIOPHARMA, INC
Inventors:
John M. McCall, Eric Hoffman, Kanneboyina Nagaraju
Abstract: The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-?B for the treatment or prevention of muscular wasting disease, including muscular dystrophy.
Type:
Grant
Filed:
May 28, 2009
Date of Patent:
June 26, 2012
Assignee:
Validus Biopharma Inc.
Inventors:
John M. McCall, Eric Hoffman, Kanneboyina Nagaraju